Trustcore Financial Services, LLC Ironwood Pharmaceuticals Inc Transaction History

Trustcore Financial Services, LLC

  • $1.13 Billion
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 30, 2020
SELL
$8.22 - $14.0 $246,600 - $420,000
-30,000 Closed
0 $0
Q1 2019

May 07, 2019
SELL
$8.27 - $12.73 $610,656 - $939,983
-73,840 Reduced 71.11%
30,000 $406,000
Q3 2018

Nov 09, 2018
BUY
$14.31 - $17.65 $1.49 Million - $1.83 Million
103,840 New
103,840 $1.92 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $645M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email